Wire · opportunities
Abbott earns FDA approval for new dual-energy ablation catheter
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 9 September 2026 · Fusion42 review
Abbott received FDA approval for the TactiFlex Duo sensor-enabled dual-energy ablation catheter, which allows electrophysiologists to switch between pulsed-field ablation and radiofrequency energy in atrial fibrillation treatment. The device builds on prior FDA breakthrough designation and CE mark clearance and demonstrated strong clinical outcomes in maintaining arrhythmia-free patients.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it.
◆ ◆ The Wire takeaway
You need to prioritize integrating dual-energy ablation technology into your offering as regulation now allows combining two leading treatment modes in one device, shifting clinical practice. Abbott's approval signals escalating expectations for flexible electrophysiology tools tailored to complex arrhythmia cases.
◆ Coverage
3 sources · 8 Sep 2026
◆ Related on Wire
◆ Topics